Visual Feedback of Tongue by Ultrasound Echography for Speech Trouble Rehabilitation (NCT02752425) | Clinical Trial Compass
CompletedNot Applicable
Visual Feedback of Tongue by Ultrasound Echography for Speech Trouble Rehabilitation
France18 participantsStarted 2016-05-30
Plain-language summary
Speech is a privileged means of communication for humans: its trouble can thus prove being extremely handicapping. Standard speech therapy is limited in some cases by the lack of sensory feedback available to the patient (hearing, surgery, neural damage, etc.).
The present study aims at quantify the contribution of the tongue articulatory visual feedback offered by ultrasound echography to speech trouble rehabilitation.
Two complementary populations will be studied : 30 adults with buccopharyngeal surgery, and 10 childrens with important speech troubles due to central nervous system damage.
The principle is to conduct standard speech therapy sessions, alternating series of sessions with the use of visual feedback and sessions without visual feedback.
The progress will be regularly measured by means of standard batteries of speech articulation tests.
Who can participate
Age range
8 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Articulatory troubles needing speech therapy
* French mother tongue
* Adult patients \[18 ≥ age \< 80 years\] who underwent buccopharyngeal surgery after cancer diagnostic OR children \[8 ≥ age \< 18 years\] suffering from central nervous system damage
Exclusion Criteria:
* Incapacity to easily understand the speech therapist instructions
* People protected by the law
* People deprived from freedom by judiciary decision
* Potential allergy to the water-based conducting gel used to ensure good skin - probe contact
* Overweight if large fatty mass under chin
* Major edema under chin limiting echogenicity
* Non corrected vision or hearing problems
* For the adults: central or peripheral neural damage
* History of Ear, Nose, and Throat surgery or radiotherapy
* For the adults: isolated articulatory trouble, former articulatory trouble not treated, disfluency
* Massive orofacial dyspraxia
* Posture trouble
* Motor problem in upper limbs
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.